List of Tables
Table 1. Premenstrual Syndrome Treatment Market Trends
Table 2. Premenstrual Syndrome Treatment Market Drivers & Opportunity
Table 3. Premenstrual Syndrome Treatment Market Challenges
Table 4. Premenstrual Syndrome Treatment Market Restraints
Table 5. Global Premenstrual Syndrome Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Premenstrual Syndrome Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Premenstrual Syndrome Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Premenstrual Syndrome Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Premenstrual Syndrome Treatment
Table 10. Global Premenstrual Syndrome Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premenstrual Syndrome Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Premenstrual Syndrome Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Premenstrual Syndrome Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Premenstrual Syndrome Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Premenstrual Syndrome Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Premenstrual Syndrome Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Premenstrual Syndrome Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Premenstrual Syndrome Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Premenstrual Syndrome Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Premenstrual Syndrome Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Premenstrual Syndrome Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Premenstrual Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Premenstrual Syndrome Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Premenstrual Syndrome Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Premenstrual Syndrome Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Premenstrual Syndrome Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Premenstrual Syndrome Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Premenstrual Syndrome Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Premenstrual Syndrome Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. AbbVie Basic Information List
Table 32. AbbVie Description and Business Overview
Table 33. AbbVie Premenstrual Syndrome Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of AbbVie (2019-2024)
Table 35. AbbVie Recent Developments
Table 36. AstraZeneca Basic Information List
Table 37. AstraZeneca Description and Business Overview
Table 38. AstraZeneca Premenstrual Syndrome Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of AstraZeneca (2019-2024)
Table 40. AstraZeneca Recent Developments
Table 41. BASF Corporation Basic Information List
Table 42. BASF Corporation Description and Business Overview
Table 43. BASF Corporation Premenstrual Syndrome Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of BASF Corporation (2019-2024)
Table 45. BASF Corporation Recent Developments
Table 46. Bayer Basic Information List
Table 47. Bayer Description and Business Overview
Table 48. Bayer Premenstrual Syndrome Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of Bayer (2019-2024)
Table 50. Bayer Recent Developments
Table 51. Eli Lilly And Company Basic Information List
Table 52. Eli Lilly And Company Description and Business Overview
Table 53. Eli Lilly And Company Premenstrual Syndrome Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of Eli Lilly And Company (2019-2024)
Table 55. Eli Lilly And Company Recent Developments
Table 56. GlaxoSmithKline Basic Information List
Table 57. GlaxoSmithKline Description and Business Overview
Table 58. GlaxoSmithKline Premenstrual Syndrome Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of GlaxoSmithKline (2019-2024)
Table 60. GlaxoSmithKline Recent Developments
Table 61. Pfizer Basic Information List
Table 62. Pfizer Description and Business Overview
Table 63. Pfizer Premenstrual Syndrome Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of Pfizer (2019-2024)
Table 65. Pfizer Recent Developments
Table 66. Shionogi Basic Information List
Table 67. Shionogi Description and Business Overview
Table 68. Shionogi Premenstrual Syndrome Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of Shionogi (2019-2024)
Table 70. Shionogi Recent Developments
Table 71. Johnson & Johnson Basic Information List
Table 72. Johnson & Johnson Description and Business Overview
Table 73. Johnson & Johnson Premenstrual Syndrome Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of Johnson & Johnson (2019-2024)
Table 75. Johnson & Johnson Recent Developments
Table 76. Novartis AG Basic Information List
Table 77. Novartis AG Description and Business Overview
Table 78. Novartis AG Premenstrual Syndrome Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of Novartis AG (2019-2024)
Table 80. Novartis AG Recent Developments
Table 81. Merck & Co., Inc. Basic Information List
Table 82. Merck & Co., Inc. Description and Business Overview
Table 83. Merck & Co., Inc. Premenstrual Syndrome Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of Merck & Co., Inc. (2019-2024)
Table 85. Merck & Co., Inc. Recent Developments
Table 86. Allergan plc Basic Information List
Table 87. Allergan plc Description and Business Overview
Table 88. Allergan plc Premenstrual Syndrome Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of Allergan plc (2019-2024)
Table 90. Allergan plc Recent Developments
Table 91. Mylan N.V. Basic Information List
Table 92. Mylan N.V. Description and Business Overview
Table 93. Mylan N.V. Premenstrual Syndrome Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Premenstrual Syndrome Treatment Business of Mylan N.V. (2019-2024)
Table 95. Mylan N.V. Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Premenstrual Syndrome Treatment Downstream Customers
Table 99. Premenstrual Syndrome Treatment Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Premenstrual Syndrome Treatment Product Picture
Figure 2. Global Premenstrual Syndrome Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Premenstrual Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Premenstrual Syndrome Treatment Report Years Considered
Figure 5. Global Premenstrual Syndrome Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Premenstrual Syndrome Treatment Revenue in 2023
Figure 7. Premenstrual Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Medication Picture
Figure 9. Dietary Treatment Picture
Figure 10. Emotional Treatment Picture
Figure 11. Hormone Therapy Picture
Figure 12. Others Picture
Figure 13. Global Premenstrual Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Premenstrual Syndrome Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Younger than 20 Years
Figure 16. Product Picture of 20-40 Years Old Adults
Figure 17. Global Premenstrual Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Premenstrual Syndrome Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Premenstrual Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Premenstrual Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Premenstrual Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Premenstrual Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Premenstrual Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Premenstrual Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Premenstrual Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Premenstrual Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Premenstrual Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Premenstrual Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Premenstrual Syndrome Treatment Sales Value (%), (2019-2030)
Figure 30. United States Premenstrual Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Premenstrual Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Premenstrual Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Premenstrual Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Premenstrual Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Premenstrual Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 36. China Premenstrual Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Premenstrual Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 38. China Premenstrual Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Premenstrual Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Premenstrual Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Premenstrual Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Premenstrual Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Premenstrual Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Premenstrual Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Premenstrual Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Premenstrual Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Premenstrual Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. India Premenstrual Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Premenstrual Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. India Premenstrual Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. Premenstrual Syndrome Treatment Industrial Chain
Figure 52. Premenstrual Syndrome Treatment Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
